Rapid and Sensitive SARS-CoV-2 Detection Using a New Diagnostic Platform
Author Information
Author(s): Kyung Kangwuk, Lee Hyojin, Kim Soo-Kyung, Kim Dong-Eun
Primary Institution: Konkuk University
Hypothesis
Can a nucleic acid lateral flow assay (NALFA) combined with isothermal gene amplification effectively detect SARS-CoV-2 RNA?
Conclusion
The developed diagnostic platform can detect SARS-CoV-2 RNA concentrations as low as 3.1 cp/μL in under 1 hour, with results consistent with conventional RT-qPCR.
Supporting Evidence
- The diagnostic platform achieved results in less than 1 hour.
- It detected viral RNA concentrations as low as 3.1 cp/μL.
- The results were 100% consistent with conventional RT-qPCR.
- The platform is more sensitive than rapid antigen tests.
Takeaway
Scientists created a new test that can quickly find the virus that causes COVID-19, even when there's only a tiny bit of it.
Methodology
The study used a nucleic acid lateral flow assay combined with isothermal gene amplification to detect SARS-CoV-2 RNA in clinical samples.
Limitations
The study primarily focused on SARS-CoV-2 and may not be generalizable to other viruses.
Participant Demographics
Nasopharyngeal swab samples from patients with confirmed SARS-CoV-2 infection.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website